CN Stock MarketDetailed Quotes

Cisen Pharmaceutical (603367)

Watchlist
  • 15.15
  • -0.27-1.75%
Market Closed May 14 15:00 CST
6.86BMarket Cap16.80P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cisen Pharmaceutical (603367) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
-7.59%850.35M
-13.48%3.44B
-13.94%2.58B
-15.97%1.74B
-19.91%920.2M
-10.77%3.98B
-6.47%3B
-6.72%2.07B
1.28%1.15B
9.75%4.46B
Operating revenue
-7.59%850.35M
-13.48%3.44B
-13.94%2.58B
-15.97%1.74B
-19.91%920.2M
-10.77%3.98B
-6.47%3B
-6.72%2.07B
1.28%1.15B
9.75%4.46B
Other operating revenue
----
75.33%17.56M
----
3.50%3.45M
----
-10.08%10.02M
----
-9.24%3.33M
----
-33.81%11.14M
Total operating cost
-6.91%690.43M
-11.32%3.09B
-14.86%2.23B
-17.06%1.49B
-22.32%741.66M
-9.91%3.48B
-6.66%2.62B
-7.19%1.8B
-1.01%954.82M
4.01%3.87B
Operating cost
-3.60%357.36M
-4.15%1.66B
-9.70%1.16B
-12.82%762.69M
-14.67%370.72M
-5.98%1.73B
-6.78%1.29B
-11.65%874.86M
3.21%434.45M
2.78%1.84B
Operating tax surcharges
1.51%12.06M
-7.08%45.37M
-9.54%33M
-14.47%21.72M
-15.14%11.88M
-17.77%48.83M
-13.87%36.48M
-16.94%25.39M
-10.71%14M
7.25%59.38M
Operating expense
-13.89%196.16M
-18.81%888.22M
-22.84%633.3M
-26.18%442.38M
-33.08%227.82M
-18.03%1.09B
-13.30%820.79M
-8.20%599.25M
-9.17%340.42M
2.20%1.33B
Administration expense
7.35%67.95M
-19.50%242.61M
-12.08%197.68M
-4.64%132.66M
-17.10%63.3M
3.07%301.38M
9.79%224.84M
8.78%139.11M
8.55%76.35M
12.60%292.41M
Financial expense
19.89%-4.57M
7.27%-30.12M
21.94%-18.54M
29.96%-12.04M
45.59%-5.7M
3.53%-32.48M
6.26%-23.75M
-1.58%-17.18M
-17.30%-10.48M
-20.79%-33.67M
-Interest expense (Financial expense)
-71.38%66.59K
-80.77%1.34M
-91.42%487.6K
-76.01%644.99K
-82.74%232.65K
5.48%6.95M
15.40%5.68M
-11.64%2.69M
20.13%1.35M
53.34%6.59M
-Interest Income (Financial expense)
-8.64%-7.02M
17.57%-32.62M
26.06%-21.19M
30.17%-14M
46.41%-6.46M
4.85%-39.57M
1.39%-28.65M
-1.06%-20.05M
-22.68%-12.05M
-21.18%-41.59M
Research and development
-16.54%61.46M
-16.59%285.78M
-18.82%221.07M
-18.50%145.96M
-26.41%73.64M
-8.60%342.64M
6.61%272.31M
15.25%179.09M
9.05%100.07M
11.85%374.88M
Credit Impairment Loss
39.99%-8.04M
-344.66%-10.19M
-195.43%-15.61M
-59.67%-13.4M
-6.81%-13.4M
278.20%4.16M
-65.40%-5.29M
-169.23%-8.39M
-83.20%-12.54M
82.11%-2.34M
Asset Impairment Loss
33.19%-28.09M
-5.54%-59.13M
-51.01%-59.78M
-16.87%-44.15M
-38.65%-42.05M
23.77%-56.03M
0.06%-39.59M
-5.58%-37.78M
-56.01%-30.33M
-346.47%-73.5M
Other net revenue
13.82%-15.68M
95.26%144.37M
36.71%67.62M
-48.63%10.33M
-56.08%-18.19M
2,494.97%73.94M
249.92%49.46M
87.78%20.11M
-1,141.00%-11.65M
-119.16%-3.09M
Fair value change income
-346.75%-13.18M
276.89%39.68M
-3.94%23.87M
147.59%20.86M
357.26%5.34M
201.48%10.53M
181.34%24.84M
-68.18%8.43M
-112.04%-2.08M
-232.56%-10.37M
Invest income
2.11%28.21M
98.17%123.47M
316.41%98.43M
89.31%34.67M
154.79%27.63M
41.22%62.3M
-19.05%23.64M
17.36%18.31M
57.46%10.84M
136.18%44.12M
-Including: Investment income associates
----
----
50,107.67%60.53K
11,434.98%13.91K
---30.86K
-465.78%-483.81K
-99.97%120.55
-99.95%120.55
----
117.58%132.27K
Asset deal income
-79.94%87.22K
-407.00%-707.42K
2,893.33%397.95K
1,496.45%419.69K
-82.74%434.73K
-123.48%-139.53K
-97.67%13.29K
-95.66%26.29K
5,811.69%2.52M
-39.03%594.29K
Other revenue
38.49%5.33M
-3.50%51.25M
-55.67%20.32M
-69.79%11.94M
-80.68%3.85M
38.27%53.11M
149.98%45.84M
470.68%39.52M
517.56%19.93M
31.98%38.41M
Operating profit
-10.05%144.25M
-12.62%499.88M
-2.64%424.29M
-11.51%256.73M
-12.12%160.36M
-3.46%572.05M
3.42%435.81M
-0.11%290.12M
6.74%182.48M
62.54%592.58M
Add:Non operating Income
10.80%522.38K
-45.82%2.65M
-53.27%1.84M
-68.10%854.93K
-64.33%471.48K
-21.10%4.9M
76.84%3.93M
50.35%2.68M
3.26%1.32M
2.88%6.21M
Less:Non operating expense
13.13%915.02K
440.93%6.34M
252.63%2.82M
54.79%1.14M
677.73%808.86K
-59.98%1.17M
-47.60%799.25K
-50.60%736.05K
-88.74%104K
-33.81%2.93M
Total profit
-10.10%143.85M
-13.82%496.19M
-3.56%423.31M
-12.19%256.45M
-12.89%160.02M
-3.37%575.77M
3.99%438.94M
0.46%292.06M
7.23%183.69M
62.72%595.86M
Less:Income tax cost
-23.80%11.74M
16.02%70.58M
6.97%38.07M
37.15%25.16M
-28.37%15.41M
-13.63%60.83M
34.19%35.59M
-23.02%18.35M
52.58%21.51M
405.97%70.43M
Net profit
-8.64%132.11M
-17.35%425.62M
-4.49%385.24M
-15.50%231.29M
-10.83%144.61M
-2.00%514.94M
1.96%403.35M
2.56%273.72M
3.16%162.18M
49.15%525.43M
Net profit from continuing operation
-8.64%132.11M
-17.35%425.62M
-4.49%385.24M
-15.50%231.29M
-10.83%144.61M
-2.00%514.94M
1.96%403.35M
2.56%273.72M
3.16%162.18M
49.15%525.43M
Less:Minority Profit
28.09%1.37M
-27.59%4.37M
-38.32%3.23M
-37.13%2.14M
256.49%1.07M
47.61%6.03M
1.83%5.23M
24.25%3.4M
-150.29%-681.86K
76.75%4.09M
Net profit of parent company owners
-8.92%130.75M
-17.22%421.25M
-4.05%382.01M
-15.23%229.15M
-11.86%143.54M
-2.38%508.91M
1.97%398.12M
2.33%270.32M
4.50%162.86M
48.97%521.34M
Earning per share
Basic earning per share
-9.38%0.29
-16.96%0.93
-4.55%0.84
-15.00%0.51
-11.11%0.32
-2.61%1.12
2.33%0.88
3.45%0.6
5.88%0.36
49.35%1.15
Diluted earning per share
-9.38%0.29
-16.96%0.93
-4.55%0.84
-15.00%0.51
-11.11%0.32
-2.61%1.12
2.33%0.88
3.45%0.6
5.88%0.36
49.35%1.15
Other composite income
-95.38%21.03K
377.41%58.5K
169.34%455.21K
0.85%455.21K
-74.20%455.21K
-108.62%-21.09K
81.13%-656.48K
155.90%451.37K
9,924.36%1.76M
360.50%244.78K
Other composite income of parent company owners
-95.38%21.03K
377.41%58.5K
169.34%455.21K
0.85%455.21K
-74.20%455.21K
-108.62%-21.09K
81.13%-656.48K
155.90%451.37K
9,924.36%1.76M
360.50%244.78K
Total composite income
-8.92%132.13M
-17.33%425.68M
-4.22%385.7M
-15.47%231.74M
-11.52%145.07M
-2.05%514.92M
2.70%402.7M
3.04%274.17M
4.28%163.95M
49.26%525.67M
Total composite income of parent company owners
-9.19%130.77M
-17.21%421.31M
-3.77%382.47M
-15.20%229.61M
-12.53%144M
-2.43%508.89M
2.71%397.46M
2.82%270.77M
5.62%164.63M
49.08%521.58M
Total composite income of minority owners
28.09%1.37M
-27.59%4.37M
-38.32%3.23M
-37.13%2.14M
256.49%1.07M
47.61%6.03M
1.83%5.23M
24.25%3.4M
-150.29%-681.86K
76.75%4.09M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue -7.59%850.35M-13.48%3.44B-13.94%2.58B-15.97%1.74B-19.91%920.2M-10.77%3.98B-6.47%3B-6.72%2.07B1.28%1.15B9.75%4.46B
Operating revenue -7.59%850.35M-13.48%3.44B-13.94%2.58B-15.97%1.74B-19.91%920.2M-10.77%3.98B-6.47%3B-6.72%2.07B1.28%1.15B9.75%4.46B
Other operating revenue ----75.33%17.56M----3.50%3.45M-----10.08%10.02M-----9.24%3.33M-----33.81%11.14M
Total operating cost -6.91%690.43M-11.32%3.09B-14.86%2.23B-17.06%1.49B-22.32%741.66M-9.91%3.48B-6.66%2.62B-7.19%1.8B-1.01%954.82M4.01%3.87B
Operating cost -3.60%357.36M-4.15%1.66B-9.70%1.16B-12.82%762.69M-14.67%370.72M-5.98%1.73B-6.78%1.29B-11.65%874.86M3.21%434.45M2.78%1.84B
Operating tax surcharges 1.51%12.06M-7.08%45.37M-9.54%33M-14.47%21.72M-15.14%11.88M-17.77%48.83M-13.87%36.48M-16.94%25.39M-10.71%14M7.25%59.38M
Operating expense -13.89%196.16M-18.81%888.22M-22.84%633.3M-26.18%442.38M-33.08%227.82M-18.03%1.09B-13.30%820.79M-8.20%599.25M-9.17%340.42M2.20%1.33B
Administration expense 7.35%67.95M-19.50%242.61M-12.08%197.68M-4.64%132.66M-17.10%63.3M3.07%301.38M9.79%224.84M8.78%139.11M8.55%76.35M12.60%292.41M
Financial expense 19.89%-4.57M7.27%-30.12M21.94%-18.54M29.96%-12.04M45.59%-5.7M3.53%-32.48M6.26%-23.75M-1.58%-17.18M-17.30%-10.48M-20.79%-33.67M
-Interest expense (Financial expense) -71.38%66.59K-80.77%1.34M-91.42%487.6K-76.01%644.99K-82.74%232.65K5.48%6.95M15.40%5.68M-11.64%2.69M20.13%1.35M53.34%6.59M
-Interest Income (Financial expense) -8.64%-7.02M17.57%-32.62M26.06%-21.19M30.17%-14M46.41%-6.46M4.85%-39.57M1.39%-28.65M-1.06%-20.05M-22.68%-12.05M-21.18%-41.59M
Research and development -16.54%61.46M-16.59%285.78M-18.82%221.07M-18.50%145.96M-26.41%73.64M-8.60%342.64M6.61%272.31M15.25%179.09M9.05%100.07M11.85%374.88M
Credit Impairment Loss 39.99%-8.04M-344.66%-10.19M-195.43%-15.61M-59.67%-13.4M-6.81%-13.4M278.20%4.16M-65.40%-5.29M-169.23%-8.39M-83.20%-12.54M82.11%-2.34M
Asset Impairment Loss 33.19%-28.09M-5.54%-59.13M-51.01%-59.78M-16.87%-44.15M-38.65%-42.05M23.77%-56.03M0.06%-39.59M-5.58%-37.78M-56.01%-30.33M-346.47%-73.5M
Other net revenue 13.82%-15.68M95.26%144.37M36.71%67.62M-48.63%10.33M-56.08%-18.19M2,494.97%73.94M249.92%49.46M87.78%20.11M-1,141.00%-11.65M-119.16%-3.09M
Fair value change income -346.75%-13.18M276.89%39.68M-3.94%23.87M147.59%20.86M357.26%5.34M201.48%10.53M181.34%24.84M-68.18%8.43M-112.04%-2.08M-232.56%-10.37M
Invest income 2.11%28.21M98.17%123.47M316.41%98.43M89.31%34.67M154.79%27.63M41.22%62.3M-19.05%23.64M17.36%18.31M57.46%10.84M136.18%44.12M
-Including: Investment income associates --------50,107.67%60.53K11,434.98%13.91K---30.86K-465.78%-483.81K-99.97%120.55-99.95%120.55----117.58%132.27K
Asset deal income -79.94%87.22K-407.00%-707.42K2,893.33%397.95K1,496.45%419.69K-82.74%434.73K-123.48%-139.53K-97.67%13.29K-95.66%26.29K5,811.69%2.52M-39.03%594.29K
Other revenue 38.49%5.33M-3.50%51.25M-55.67%20.32M-69.79%11.94M-80.68%3.85M38.27%53.11M149.98%45.84M470.68%39.52M517.56%19.93M31.98%38.41M
Operating profit -10.05%144.25M-12.62%499.88M-2.64%424.29M-11.51%256.73M-12.12%160.36M-3.46%572.05M3.42%435.81M-0.11%290.12M6.74%182.48M62.54%592.58M
Add:Non operating Income 10.80%522.38K-45.82%2.65M-53.27%1.84M-68.10%854.93K-64.33%471.48K-21.10%4.9M76.84%3.93M50.35%2.68M3.26%1.32M2.88%6.21M
Less:Non operating expense 13.13%915.02K440.93%6.34M252.63%2.82M54.79%1.14M677.73%808.86K-59.98%1.17M-47.60%799.25K-50.60%736.05K-88.74%104K-33.81%2.93M
Total profit -10.10%143.85M-13.82%496.19M-3.56%423.31M-12.19%256.45M-12.89%160.02M-3.37%575.77M3.99%438.94M0.46%292.06M7.23%183.69M62.72%595.86M
Less:Income tax cost -23.80%11.74M16.02%70.58M6.97%38.07M37.15%25.16M-28.37%15.41M-13.63%60.83M34.19%35.59M-23.02%18.35M52.58%21.51M405.97%70.43M
Net profit -8.64%132.11M-17.35%425.62M-4.49%385.24M-15.50%231.29M-10.83%144.61M-2.00%514.94M1.96%403.35M2.56%273.72M3.16%162.18M49.15%525.43M
Net profit from continuing operation -8.64%132.11M-17.35%425.62M-4.49%385.24M-15.50%231.29M-10.83%144.61M-2.00%514.94M1.96%403.35M2.56%273.72M3.16%162.18M49.15%525.43M
Less:Minority Profit 28.09%1.37M-27.59%4.37M-38.32%3.23M-37.13%2.14M256.49%1.07M47.61%6.03M1.83%5.23M24.25%3.4M-150.29%-681.86K76.75%4.09M
Net profit of parent company owners -8.92%130.75M-17.22%421.25M-4.05%382.01M-15.23%229.15M-11.86%143.54M-2.38%508.91M1.97%398.12M2.33%270.32M4.50%162.86M48.97%521.34M
Earning per share
Basic earning per share -9.38%0.29-16.96%0.93-4.55%0.84-15.00%0.51-11.11%0.32-2.61%1.122.33%0.883.45%0.65.88%0.3649.35%1.15
Diluted earning per share -9.38%0.29-16.96%0.93-4.55%0.84-15.00%0.51-11.11%0.32-2.61%1.122.33%0.883.45%0.65.88%0.3649.35%1.15
Other composite income -95.38%21.03K377.41%58.5K169.34%455.21K0.85%455.21K-74.20%455.21K-108.62%-21.09K81.13%-656.48K155.90%451.37K9,924.36%1.76M360.50%244.78K
Other composite income of parent company owners -95.38%21.03K377.41%58.5K169.34%455.21K0.85%455.21K-74.20%455.21K-108.62%-21.09K81.13%-656.48K155.90%451.37K9,924.36%1.76M360.50%244.78K
Total composite income -8.92%132.13M-17.33%425.68M-4.22%385.7M-15.47%231.74M-11.52%145.07M-2.05%514.92M2.70%402.7M3.04%274.17M4.28%163.95M49.26%525.67M
Total composite income of parent company owners -9.19%130.77M-17.21%421.31M-3.77%382.47M-15.20%229.61M-12.53%144M-2.43%508.89M2.71%397.46M2.82%270.77M5.62%164.63M49.08%521.58M
Total composite income of minority owners 28.09%1.37M-27.59%4.37M-38.32%3.23M-37.13%2.14M256.49%1.07M47.61%6.03M1.83%5.23M24.25%3.4M-150.29%-681.86K76.75%4.09M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.39%
Sample Name
Sample Code
 +3.02%
Sample Name
Sample Code
 +1.57%
4
CNOOC
00883
+0.61%
5
SINOPEC CORP
00386
+0.44%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +47.30%
Sample Name
Sample Code
 +42.51%
Sample Name
Sample Code
 +30.01%
4
Loongson Technology Corporation
688047
+19.61%
5
Digital China Group
000034
+17.32%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -